Inflammatory Diseases

by in

Entry	Author	Date	Location
San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More	Bruce V. Bigelow	02/21/13	San Diego
U-M’s New Drug Discovery Center to Commercialize Research	Sarah Schmid	09/05/12	Detroit
Innovimmune Pursues Pharma Partners, Shuns VCs	Arlene Weintraub	08/07/12	New York
Xconomist of the Week: John Reed on Sanford-Burnham’s Drug Pipeline	Bruce V. Bigelow	08/03/12	San Diego
SD Life Sciences Roundup: Arena, PatientSafe, MEI Pharma, & More	Bruce V. Bigelow	06/28/12	San Diego
Aileron CEO Hails Expanded Roche Deal as a Validation of Stapled-Peptide Drug Technology	Arlene Weintraub	11/17/11	Boston
Xoma CEO Resigns After Four-Year Push To Go Commercial	Luke Timmerman	08/31/11	San Francisco
Dicerna Expands Kyowa Hakko Pact	Ryan McBride	12/07/10	Boston
Logical Therapeutics Closes $16.9M C Round	Ryan McBride	05/27/10	Boston
Another $8M for Dyax in Stock Deal	Erin Kutz	04/05/10	Boston
Epizyme Snags $32M Round to Make Drugs Against Cancer and More	Luke Timmerman	10/07/09	Boston
Axikin Raises $3M After Spinning Out From Actimis	Ryan McBride	01/22/09	San Diego
CalciMedica Finds a New Pathway to Fight Autoimmune Disorders	Bruce V. Bigelow	01/09/09	San Diego
Ardea Raises $30.6M in Stock Sale	Gregory T. Huang	12/19/08	San Diego
Clinical Data Acquires Adenosine To Expand Drug Pipeline	Luke Timmerman	08/05/08	Boston
Page 1 of 1

Xconomy National